These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 10972493)

  • 21. Capsule and melanin synthesis in Cryptococcus neoformans.
    McFadden DC; Casadevall A
    Med Mycol; 2001; 39 Suppl 1():19-30. PubMed ID: 11800266
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Measuring Laccase Activity and Melanin Production in Cryptococcus neoformans.
    Albuquerque P; de Sousa HR; de Oliveira Frazão S; do Nascimento Miranda LV; Paes HC; Pereira IS; Nicola AM
    Methods Mol Biol; 2024; 2775():257-268. PubMed ID: 38758323
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Establishment of protective immunity against cerebral cryptococcosis by means of an avirulent, non melanogenic Cryptococcus neoformans strain.
    Barluzzi R; Brozzetti A; Mariucci G; Tantucci M; Neglia RG; Bistoni F; Blasi E
    J Neuroimmunol; 2000 Sep; 109(2):75-86. PubMed ID: 10996209
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relationship between superoxide dismutase and melanin in a pathogenic fungus.
    Jacobson ES; Jenkins ND; Todd JM
    Infect Immun; 1994 Sep; 62(9):4085-6. PubMed ID: 8063430
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The iron- and cAMP-regulated gene SIT1 influences ferrioxamine B utilization, melanization and cell wall structure in Cryptococcus neoformans.
    Tangen KL; Jung WH; Sham AP; Lian T; Kronstad JW
    Microbiology (Reading); 2007 Jan; 153(Pt 1):29-41. PubMed ID: 17185532
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phenotypic switching in Cryptococcus neoformans.
    Fries BC; Goldman DL; Casadevall A
    Microbes Infect; 2002 Nov; 4(13):1345-52. PubMed ID: 12443899
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A CLC-type chloride channel gene is required for laccase activity and virulence in Cryptococcus neoformans.
    Zhu X; Williamson PR
    Mol Microbiol; 2003 Nov; 50(4):1271-81. PubMed ID: 14622414
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Growth on Douglas fir media facilitates Cryptococcus virulence factor production and enhances fungal survival against environmental and immune stressors.
    Stempinski PR; Greengo SD; Casadevall A
    Med Mycol; 2024 Jul; 62(7):. PubMed ID: 38982313
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Melanization decreases the susceptibility of Cryptococcus neoformans to enzymatic degradation.
    Rosas AL; Casadevall A
    Mycopathologia; 2001; 151(2):53-6. PubMed ID: 11554578
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 'Ready made' virulence and 'dual use' virulence factors in pathogenic environmental fungi--the Cryptococcus neoformans paradigm.
    Casadevall A; Steenbergen JN; Nosanchuk JD
    Curr Opin Microbiol; 2003 Aug; 6(4):332-7. PubMed ID: 12941400
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cryptococcus neoformans can utilize the bacterial melanin precursor homogentisic acid for fungal melanogenesis.
    Frases S; Salazar A; Dadachova E; Casadevall A
    Appl Environ Microbiol; 2007 Jan; 73(2):615-21. PubMed ID: 17098915
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Microevolution of a standard strain of Cryptococcus neoformans resulting in differences in virulence and other phenotypes.
    Franzot SP; Mukherjee J; Cherniak R; Chen LC; Hamdan JS; Casadevall A
    Infect Immun; 1998 Jan; 66(1):89-97. PubMed ID: 9423844
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis of polymerized melanin by Cryptococcus neoformans in infected rodents.
    Rosas AL; Nosanchuk JD; Feldmesser M; Cox GM; McDade HC; Casadevall A
    Infect Immun; 2000 May; 68(5):2845-53. PubMed ID: 10768981
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of laccases and melanization in clinical and environmental Cryptococcus neoformans samples by non-denaturing PAGE.
    Pereira CB; Bueno FL; Dias ALT; Brigagão MRPL; Paula CR; Siqueira AM
    J Med Microbiol; 2009 May; 58(Pt 5):563-566. PubMed ID: 19369516
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Melanization of Cryptococcus neoformans in murine infection.
    Nosanchuk JD; Valadon P; Feldmesser M; Casadevall A
    Mol Cell Biol; 1999 Jan; 19(1):745-50. PubMed ID: 9858597
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Signal transduction pathways regulating differentiation and pathogenicity of Cryptococcus neoformans.
    Alspaugh JA; Perfect JR; Heitman J
    Fungal Genet Biol; 1998 Oct; 25(1):1-14. PubMed ID: 9806801
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Variation in chromosome copy number influences the virulence of Cryptococcus neoformans and occurs in isolates from AIDS patients.
    Hu G; Wang J; Choi J; Jung WH; Liu I; Litvintseva AP; Bicanic T; Aurora R; Mitchell TG; Perfect JR; Kronstad JW
    BMC Genomics; 2011 Oct; 12():526. PubMed ID: 22032296
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of laccase in the biology and virulence of Cryptococcus neoformans.
    Zhu X; Williamson PR
    FEMS Yeast Res; 2004 Oct; 5(1):1-10. PubMed ID: 15381117
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of ENA1 as a virulence gene of the human pathogenic fungus Cryptococcus neoformans through signature-tagged insertional mutagenesis.
    Idnurm A; Walton FJ; Floyd A; Reedy JL; Heitman J
    Eukaryot Cell; 2009 Mar; 8(3):315-26. PubMed ID: 19151325
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transcriptional network of multiple capsule and melanin genes governed by the Cryptococcus neoformans cyclic AMP cascade.
    Pukkila-Worley R; Gerrald QD; Kraus PR; Boily MJ; Davis MJ; Giles SS; Cox GM; Heitman J; Alspaugh JA
    Eukaryot Cell; 2005 Jan; 4(1):190-201. PubMed ID: 15643074
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.